Henan Lingrui Pharmaceutical Co Ltd
SSE:600285

Watchlist Manager
Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Watchlist
Price: 20.81 CNY -3.88% Market Closed
Market Cap: 11.6B CNY
Have any thoughts about
Henan Lingrui Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Henan Lingrui Pharmaceutical Co Ltd stock under the Base Case scenario is 32.2 CNY. Compared to the current market price of 20.81 CNY, Henan Lingrui Pharmaceutical Co Ltd is Undervalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
32.2 CNY
Undervaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Henan Lingrui Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Henan Lingrui Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Henan Lingrui Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Henan Lingrui Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Henan Lingrui Pharmaceutical Co Ltd.

What unique competitive advantages
does Henan Lingrui Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Henan Lingrui Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Henan Lingrui Pharmaceutical Co Ltd.

Provide P/S
for Henan Lingrui Pharmaceutical Co Ltd.

Provide P/E
for Henan Lingrui Pharmaceutical Co Ltd.

Provide P/OCF
for Henan Lingrui Pharmaceutical Co Ltd.

Provide P/FCFE
for Henan Lingrui Pharmaceutical Co Ltd.

Provide P/B
for Henan Lingrui Pharmaceutical Co Ltd.

Provide EV/S
for Henan Lingrui Pharmaceutical Co Ltd.

Provide EV/GP
for Henan Lingrui Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Henan Lingrui Pharmaceutical Co Ltd.

Provide EV/EBIT
for Henan Lingrui Pharmaceutical Co Ltd.

Provide EV/OCF
for Henan Lingrui Pharmaceutical Co Ltd.

Provide EV/FCFF
for Henan Lingrui Pharmaceutical Co Ltd.

Provide EV/IC
for Henan Lingrui Pharmaceutical Co Ltd.

Show me price targets
for Henan Lingrui Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Henan Lingrui Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Henan Lingrui Pharmaceutical Co Ltd?

What are the Net Income projections
for Henan Lingrui Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Henan Lingrui Pharmaceutical Co Ltd?

What are the EPS projections
for Henan Lingrui Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Henan Lingrui Pharmaceutical Co Ltd?

What are the EBIT projections
for Henan Lingrui Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Henan Lingrui Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Henan Lingrui Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Henan Lingrui Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Henan Lingrui Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Henan Lingrui Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Henan Lingrui Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Henan Lingrui Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Henan Lingrui Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Henan Lingrui Pharmaceutical Co Ltd.

Provide ROE
for Henan Lingrui Pharmaceutical Co Ltd.

Provide ROA
for Henan Lingrui Pharmaceutical Co Ltd.

Provide ROIC
for Henan Lingrui Pharmaceutical Co Ltd.

Provide ROCE
for Henan Lingrui Pharmaceutical Co Ltd.

Provide Gross Margin
for Henan Lingrui Pharmaceutical Co Ltd.

Provide Operating Margin
for Henan Lingrui Pharmaceutical Co Ltd.

Provide Net Margin
for Henan Lingrui Pharmaceutical Co Ltd.

Provide FCF Margin
for Henan Lingrui Pharmaceutical Co Ltd.

Show all solvency ratios
for Henan Lingrui Pharmaceutical Co Ltd.

Provide D/E Ratio
for Henan Lingrui Pharmaceutical Co Ltd.

Provide D/A Ratio
for Henan Lingrui Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Henan Lingrui Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Henan Lingrui Pharmaceutical Co Ltd.

Provide Quick Ratio
for Henan Lingrui Pharmaceutical Co Ltd.

Provide Current Ratio
for Henan Lingrui Pharmaceutical Co Ltd.

Provide Cash Ratio
for Henan Lingrui Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Henan Lingrui Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Henan Lingrui Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Henan Lingrui Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Henan Lingrui Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Henan Lingrui Pharmaceutical Co Ltd

Current Assets 2.1B
Cash & Short-Term Investments 907.7m
Receivables 721.3m
Other Current Assets 470.6m
Non-Current Assets 2.6B
Long-Term Investments 1.5B
PP&E 654.5m
Intangibles 226.4m
Other Non-Current Assets 214.6m
Current Liabilities 1.9B
Accounts Payable 91.2m
Accrued Liabilities 1.3B
Short-Term Debt 96.1m
Other Current Liabilities 495.2m
Non-Current Liabilities 71.7m
Long-Term Debt 6.8m
Other Non-Current Liabilities 64.9m
Efficiency

Earnings Waterfall
Henan Lingrui Pharmaceutical Co Ltd

Revenue
3.6B CNY
Cost of Revenue
-985.6m CNY
Gross Profit
2.6B CNY
Operating Expenses
-1.9B CNY
Operating Income
720.7m CNY
Other Expenses
-44.9m CNY
Net Income
675.8m CNY

Free Cash Flow Analysis
Henan Lingrui Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Henan Lingrui Pharmaceutical Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive ROE
67/100
Profitability
Score

Henan Lingrui Pharmaceutical Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Henan Lingrui Pharmaceutical Co Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
77/100
Solvency
Score

Henan Lingrui Pharmaceutical Co Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Henan Lingrui Pharmaceutical Co Ltd

Wall Street analysts forecast Henan Lingrui Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Henan Lingrui Pharmaceutical Co Ltd is 30.65 CNY with a low forecast of 29.9 CNY and a high forecast of 32.03 CNY.

Lowest
Price Target
29.9 CNY
44% Upside
Average
Price Target
30.65 CNY
47% Upside
Highest
Price Target
32.03 CNY
54% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Henan Lingrui Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Henan Lingrui Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

11.7B CNY

Dividend Yield

0%

Description

Henan Lingrui Pharmaceutical Co., Ltd. engages in the production and sale of medicine and health products. The company is headquartered in Xinyang, Henan and currently employs 2,500 full-time employees. The company went IPO on 2000-10-18. The firm's products include emplastrum, tablets, capsules, ointments and others, applied in the treatment of diabetes mellitus, osteoarthritis, gastropathy, cardiovascular and cerebrovascular diseases, respiratory disease, gynecopathy and dermatopathy, among others. The firm distributes its products throughout China, with Henan Province and Beijing as its major markets.

Contact

HENAN
Xinyang
No.666, Jiangjun Road, Xinxian County
+863762973569
www.lingrui.com

IPO

2000-10-18

Employees

2 500

Officers

Chairman & GM
Mr. Wei Xiong
Chief Financial Officer
Mr. Peng Yu
Deputy GM & Director
Ms. Yan Chen
Secretary of the Board & Director
Mr. Guo Xin Feng
Deputy General Manager
Mr. Lei Li

See Also

Discover More
What is the Intrinsic Value of one Henan Lingrui Pharmaceutical Co Ltd stock?

The intrinsic value of one Henan Lingrui Pharmaceutical Co Ltd stock under the Base Case scenario is 32.2 CNY.

Is Henan Lingrui Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 20.81 CNY, Henan Lingrui Pharmaceutical Co Ltd is Undervalued by 35%.

Back to Top